FALLOPIAN TUBE CARCINOMA
Clinical trials for FALLOPIAN TUBE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CARCINOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial targets Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis study is testing a new type of treatment called CAR-NK cell therapy for women with ovarian cancer that has come back or stopped responding to standard treatments. Doctors first check the patient's tumor for specific markers and then give them a personalized infusion of modif…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Blood-Saving technique could transform ovarian cancer surgery
Disease control Recruiting nowThis study is testing whether a blood conservation technique called acute normovolemic hemodilution (ANH) can reduce the need for donor blood transfusions during ovarian cancer surgery. Researchers will randomly assign 86 patients undergoing surgery for advanced ovarian cancer to…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 09, 2026 14:27 UTC
-
Cancer care comes home: study tests if home treatment beats clinic visits
Symptom relief Recruiting nowThis study is testing whether cancer patients prefer to receive their standard drug treatments at home instead of in a clinic. Researchers want to see if home-based care reduces the burden of travel and improves treatment satisfaction and quality of life for patients. A specializ…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
New telehealth program aims to fight debilitating cancer fatigue
Symptom relief Recruiting nowThis study is testing a telehealth program called REVITALIZE to see if it can help reduce the severe fatigue that often interferes with daily life for people with advanced ovarian cancer who are taking PARP inhibitor medications. About 240 participants will be randomly assigned t…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Mar 19, 2026 14:56 UTC
-
Tracking cancer risk in women with BRCA genes
Knowledge-focused Recruiting nowThis study aims to understand how often and why women with BRCA gene changes develop ovarian, fallopian tube, and peritoneal cancers. Researchers will follow 600 Japanese women with these genetic variants over time, tracking who develops cancer and examining factors like lifestyl…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists build a living library of cancer to unlock treatment secrets
Knowledge-focused Recruiting nowThis study is collecting tissue and blood samples from cancer patients over time to create a research resource called a biobank. Researchers will analyze these samples to understand how cancer changes during treatment and why some treatments stop working. The goal is to help scie…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC
-
New scan aims to see inside tumors more clearly
Knowledge-focused Recruiting nowThis study is testing a new radioactive dye for PET/CT scans to see if it can better show cancer cells in people with solid tumors, including ovarian, breast, and other cancers. Researchers want to see if this new imaging method can help measure a specific protein activity inside…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC